{"The": [0, 26, 104], "mammalian": [1], "target": [2], "of": [3, 31, 45, 96, 107, 115, 149, 157, 165, 173, 184, 193, 202, 226, 236], "rapamycin": [4], "(mTOR)": [5], "is": [6, 134], "a": [7, 85], "protein": [8, 51, 61, 65], "kinase": [9, 52, 67], "that": [10, 111], "controls": [11], "cellular": [12, 24], "metabolism,": [13, 171], "catabolism,": [14], "immune": [15, 175], "responses,": [16, 176], "autophagy,": [17], "survival,": [18], "proliferation,": [19], "and": [20, 78, 100, 125, 129, 140, 153, 177, 214], "migration,": [21], "to": [22, 120], "maintain": [23], "homeostasis.": [25], "mTOR": [27, 37, 41, 82, 117, 124, 166, 194, 203, 227], "signaling": [28, 83, 167, 204, 228], "cascade": [29], "consists": [30], "two": [32], "distinct": [33], "multi-subunit": [34], "complexes": [35, 127], "named": [36], "complex": [38], "1/2": [39], "(mTORC1/2).": [40], "catalyzes": [42], "the": [43, 112, 116, 146, 154, 170, 182, 200, 220, 223, 234], "phosphorylation": [44], "several": [46], "critical": [47], "proteins": [48, 75], "like": [49], "AKT,": [50], "C,": [53], "insulin": [54], "growth": [55, 101], "factor": [56, 70, 102], "receptor": [57], "(IGF-1R),": [58], "4E": [59], "binding": [60], "1": [62], "(4E-BP1),": [63], "ribosomal": [64], "S6": [66], "(S6K),": [68], "transcription": [69], "EB": [71], "(TFEB),": [72], "sterol-responsive": [73], "element-binding": [74], "(SREBPs),": [76], "Lipin-1,": [77], "Unc-51-like": [79], "autophagy-activating": [80], "kinases.": [81], "plays": [84], "central": [86], "role": [87, 156], "in": [88, 122, 169, 205, 239], "regulating": [89], "translation,": [90], "lipid": [91], "synthesis,": [92, 94], "nucleotide": [93], "biogenesis": [95, 172], "lysosomes,": [97], "nutrient": [98], "sensing,": [99], "signaling.": [103, 195], "emerging": [105], "pieces": [106], "evidence": [108], "have": [109, 198], "revealed": [110], "constitutive": [113], "activation": [114], "pathway": [118], "due": [119], "mutations/amplification/deletion": [121], "either": [123], "its": [126, 151], "(mTORC1": [128], "mTORC2)": [130], "or": [131], "upstream": [132, 158], "targets": [133], "responsible": [135], "for": [136, 222, 233], "aging,": [137, 206], "neurological": [138, 207], "diseases,": [139], "human": [141, 209], "malignancies.": [142], "Here,": [143, 217], "we": [144, 180, 197, 218], "provide": [145], "detailed": [147], "structure": [148], "mTOR,": [150], "complexes,": [152], "comprehensive": [155], "regulators,": [159], "as": [160, 162, 189], "well": [161], "downstream": [163], "effectors": [164], "cascades": [168], "biomolecules,": [174], "autophagy.": [178], "Additionally,": [179], "summarize": [181], "potential": [183, 201], "long": [185], "noncoding": [186], "RNAs": [187], "(lncRNAs)": [188], "an": [190], "important": [191], "modulator": [192], "Importantly,": [196], "highlighted": [199], "disorders,": [208], "cancers,": [210], "cancer": [211, 237], "stem": [212], "cells,": [213], "drug": [215], "resistance.": [216], "discuss": [219], "developments": [221], "therapeutic": [224], "targeting": [225], "with": [229], "improved": [230], "anticancer": [231], "efficacy": [232], "benefit": [235], "patients": [238], "clinics.": [240]}